Skip to main content
Equibles

FEDERATED HERMES, INC.

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$39,432,894
+$24,041,239 QoQ
Shares Held
483,424
+114.0% QoQ
Ownership
0.579%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#49
of 383 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. PTCT ranks #20 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 719,905 $216,713,000
2 RYTM
Rhythm Pharmaceuticals, Inc.
 1,785,716 $198,268,046
3 REGN
Regeneron Pharmaceuticals, Inc.
 256,884 $160,177,448
4 MRNA
Moderna, Inc.
 1,794,778 $125,688,301
5 KYMR
Kymera Therapeutics, Inc.
 749,398 $85,933,468
6 EYPT
EyePoint, Inc.
 5,681,052 $81,239,042
7 ARGX
Argenx SE
 87,288 $80,983,187
8 ZBIO
Zenas BioPharma, Inc.
 3,116,805 $79,104,510

All Filings in PTCT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39,432,894 483,424
2026-03-31 $15,391,655 225,916
2025-12-31 $8,550,512 112,566
2025-09-30 $909,257 14,816
2025-06-30 $1,186,030 24,284
2025-03-31 $3,839,580 75,345
2024-12-31 $2,158,955 47,828
2023-06-30 $29,770 732
2023-03-31 $387,374 7,997
2022-09-30 $3,638,345 72,477
2021-03-31 $1,041 22
2020-12-31 $2,771,921 45,419
2020-03-31 $54,558 1,223